| ACT group (n = 20) | observation group (n = 82) | P value |
---|---|---|---|
Age | 60.90 ± 12.42197 | 6 ± 9.42682 | 0.806 |
Gender | Â | Â | 0.036* |
Male | 1(5%) | 22(26.82%) | Â |
Female | 19(95%) | 60(73.17%) | Â |
Histology | Â | Â | Â |
Adenocarcinoma | 18(90%) | 77(93.90%) | Â |
LEP | 2(10%) | 5(6.09%) | Â |
ACI-PAP | 16(80%) | 72(87.80%) | Â |
MIP-SOL | 0(0%) | 0(0%) | Â |
Squamous cell carcinoma | 2(10%) | 2(2.43%) | Â |
Poor differentiated | 0(0%) | 0(0%) | Â |
Moderate-high differentiated | 2(10%) | 2(2.43%) | Â |
Mixed | 0(0%) | 3(3.65%) | Â |
Number of resected lymph nodes | 21.23 ± 5.224 | 22.59 ± 8.779 | 0.623 |
Tumor diameter(mm) | 32.20 ± 2.52566 | 30.87 ± 2.76839 | 0.572 |
Vascular invasion | Â | Â | 0.996 |
Yes | 0(0%) | 2(2.43%) | Â |
No | 20(100%) | 80(97.56%) | Â |
Visceral pleural invasion | Â | Â | 0.984 |
Yes | 8(40%) | 33(40.24%) | Â |
No | 12(60%) | 49(59.75%) | Â |
Recurrence | Â | Â | 0.543 |
Yes | 1(5%) | 2(2.43%) | Â |
No | 19(95%) | 80(97.56%) | Â |
Death | Â | Â | 0.543 |
Yes | 1(5%) | 2(2.43%) | Â |
No | 19(95%) | 80(97.56%) | Â |